Ouathek Ouerfelli
Memorial Sloan Kettering Cancer Center(US)Kettering University(US)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis, Ubiquitin and proteasome pathways
Most-Cited Works
- → Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors(2006)827 cited
- → ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment(2012)654 cited
- → Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90(1996)407 cited
- → Loss of BAP1 function leads to EZH2-dependent transformation(2015)393 cited
- → Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer(2009)366 cited
- → Structure of Cdc42 in complex with the GTPase-binding domain of the ‘Wiskott–Aldrich syndrome’ protein(1999)319 cited